Unresectable Breast Cancer
Oncology·MeSH: Breast Neoplasms
Prevalence
287.0 / 100K
Incidence
128.0 / 100K/yr
3 drugs in development·1 company·1 clinical trial
Drug Pipeline by Phase
Phase 3(1)
| Drug | Company |
|---|---|
| Datopotamab Deruxtecan | Merus N.V. (MRUS) |
Phase 2(2)
Compare drugs
Frequently asked questions
How many drugs are in development for Unresectable Breast Cancer?
BioSniper tracks 3 drugs in development for Unresectable Breast Cancer across 1 company.
How many clinical trials target Unresectable Breast Cancer?
There are 1 clinical trial targeting Unresectable Breast Cancer tracked by BioSniper.
What is the prevalence of Unresectable Breast Cancer?
The estimated prevalence of Unresectable Breast Cancer is approximately 287.0 per 100,000 population.
Deep-dive into Unresectable Breast Cancer
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis